Industry Insights

  1. The Impact Of Waste On The Cost Of Quality In The Pharma Industry 6/22/2016

    Waste has a significant impact on the cost of quality (COQ) — or more exactly, the cost of poor quality — in the pharmaceutical industry.

  2. Keep An Eye On These Analytical And Monitoring Trends In 2025 12/20/2024

    Three experts share their thoughts on the advances and obstacles in analytical development that they're thinking about as we head into 2025.

  3. Why You Need A Document Management System In Life Sciences 8/25/2022

    In this blog we highlight the history and purpose of a document management system and look into the future with cloud-based electronic document software.

  4. Preformulation Of Excipients In Biologics Development 9/28/2023

    Most of the instability problems of a drug product come from excipients, in particular, they come from impurities in excipients. Those issues are best cleaned up in the preformulation period to determine excipient compatability.

  5. January 2025 — CDMO Opportunities And Threats Report 2/12/2025

    Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

  6. Innovative Platforms For Improved Viral Vector Development And Scale-Up 6/21/2023

    The challenges to developing AAVs or LVs necessitate expertise in productivity improvements, cell line development, CMC strategy, and platform optimization, among other variables.

  7. Mitigating Risks Through Digital Transformation 10/10/2023

    Digital solutions provide a way for CROs to not only drive operational efficiency but also build their reputations as trusted partners for drug sponsors.

  8. A Quality-Led Approach To Drug Production Facility Design 3/26/2024

    There are important considerations that architects and engineers can miss if they don't include the quality perspective. It's better to involve quality at the outset rather than discover omissions when it's too late.

  9. Advantages Of A CDMO With Internal Biosafety Testing Capabilities

    Learn about three biosafety testing methods that are commonly applied: in vitro adventitious virus (IVV), species-specific virus testing such as minute virus of mice (MVM), and mycoplasma.

  10. Will You Sink, Survive, Or Thrive In This Biotech Market Correction? 7/18/2023

    Over the past 18 months, biotech has undergone a major transformation, down from the “sugar high” of the biotech bull market and steady flow of capital in the early pandemic years. Arda Ural or Ernst & Young provides key tips for your biotech to survive and thrive during the current market correction until investment in the sector cycles back to more prosperous times.